The pain point is strategic paralysis. Manual target setting relies on static benchmarks and gut feel, creating goals that are either financially unrealistic or scientifically insufficient. This exposes companies to regulatory risk, investor skepticism, and wasted capital on misaligned initiatives. In a landscape defined by the EU's CSRD, accurate, defensible targets are now a non-negotiable operational requirement, not just a PR exercise.













